Healthcare PharmaceuticalsSandoz
Owned by Sandoz Group AG
Independent global leader in generic and biosimilar pharmaceuticals, spun off from Novartis in October 2023 and publicly traded on the SIX Swiss Exchange (SDZ), reporting 9M 2025 net sales of USD 8.057 billion with biosimilars accounting for 27% of total sales.
genericsbiosimilarspharmaceuticals